ARCHIVES

Pathology Review Confirms Reserpine As Carcinogen

This article is from The Cancer Letter archive.

Vol. 06 No. 11 | March 14, 1980

Download PDF Visit The Full Archive

Related Articles

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

Nominations sought for NCI consumer liaison group.

January 9, 2004